| [1] |
Baba Y, Watanabe M, Shigaki H, et al. Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma[J]. Surgery, 2013, 153(2): 23 4-41.
|
| [2] |
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5): 646-74.
|
| [3] |
Li T, Yang Y, Hua X, et al. Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO[J].Cancer Lett, 2012, 318(2): 154-61.
|
| [4] |
Uyttenhove C, Pilotte L, Théate I, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase[J]. Nat Med, 2003, 9(10): 12 69-74.
|
| [5] |
Wainwright DA, Balyasnikova IV, Chang AL, et al. IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival[J]. Clin Cancer Res, 2012, 18 (22): 6110-21.
|
| [6] |
Mellor AL, Munn DH. Physiologic control of the functional status of Foxp3+ regulatory T cells[J]. J Immunol, 2011, 186(8): 45 35-40.
|
| [7] |
Sharma MD, Hou DY, Baban B, et al. Reprogrammed foxp3(+) regulatory T cells provide essential help to support crosspresentation and CD8(+) T cell priming in naive mice[J]. Immunity, 2010, 33(6): 942-54.
|
| [8] |
Spranger S, Spaapen RM, Zha Y, et al. Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells[J]. Sci Transl Med, 2013, 5(200): 20 0ra116.
|
| [9] |
Gao YF, Peng RQ, Li J, et al. The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer[J]. J Transl Med, 2009, 7: 71.
|
| [10] |
Marti LC, Pavon L, Severino P, et al. Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation[J]. Mem Inst Oswaldo Cruz, 2014, 109(1): 70-9.
|
| [11] |
Giatromanolaki A, Bates GJ, Koukourakis MI, et al. The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer[J]. Gynecol Oncol, 2008, 110(2): 216-21.
|
| [12] |
Terme M, Pernot S, Marcheteau E, et al. VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer[J]. Cancer Res, 2013, 73(2): 53 9-49.
|
| [13] |
Knies-Bamforth UE, Fox SB, Poulsom R, et al. c-Myc interacts with hypoxia to induce angiogenesis in vivo by a vascular endothelial growth factor-dependent mechanism[J]. Cancer Res, 20 04, 64(18): 6563-70.
|
下载:
